KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
-9.28%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$159M
AUM Growth
+$159M
(-12%)
Cap. Flow
-$146K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
87.32%
Holding
43
New
5
Increased
6
Reduced
3
Closed
2
Top Buys
| 1 |
Anavex Life Sciences
AVXL
|
$2.6M |
| 2 |
Spero Therapeutics
SPRO
|
$609K |
| 3 |
Agnico Eagle Mines
AEM
|
$520K |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$474K |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$411K |
Top Sells
| 1 |
Blackstone
BX
|
$1M |
| 2 |
Advanced Micro Devices
AMD
|
$454K |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
$451K |
| 4 |
Soligenix
SNGX
|
$120K |
Sector Composition
| 1 | Healthcare | 86.23% |
| 2 | Materials | 3.35% |
| 3 | Technology | 2.92% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $107M | 67.04% | 900,844 +4,000 | +0.4% | +$474K |
|
2
Entera Bio
ENTX
$88.1M
| $7.13M | 4.47% | 2,484,275 | – | – |
|
|
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.76M | 3.62% | 694,232 | – | – |
|
4
Aldeyra Therapeutics
ALDX
$351M
| $3.38M | 2.12% | 759,405 | – | – |
|
5
Corbus Pharmaceuticals
CRBP
$115M
| $2.68M | 1.68% | 5,045,870 | – | – |
|
|
6
Anavex Life Sciences
AVXL
$828M
| $2.6M | 1.63% | +210,789 | New | +$2.6M |
|
7
Applied Therapeutics
APLT
$71M
| $2.28M | 1.43% | 1,082,123 +50,000 | +5% | +$105K |
|
|
8
Blackstone
BX
$134B
| $2.01M | 1.26% | 16,000 -8,000 | -33% | -$1M |
|
9
Arista Networks
ANET
$172B
| $1.92M | 1.2% | 13,800 | – | – |
|
10
CVS Health
CVS
$92.8B
| $1.46M | 0.92% | 14,500 | – | – |
|
11
Thermo Fisher Scientific
TMO
$186B
| $1.24M | 0.78% | 2,100 | – | – |
|
12
Altria Group
MO
$113B
| $1.19M | 0.74% | 22,700 | – | – |
|
13
Booz Allen Hamilton
BAH
$13.4B
| $1.14M | 0.72% | 13,000 | – | – |
|
14
Lumen
LUMN
$5.1B
| $1.13M | 0.71% | 100,000 | – | – |
|
15
Visa
V
$683B
| $1.07M | 0.67% | 4,850 | – | – |
|
16
Corning
GLW
$57.4B
| $982K | 0.62% | 26,600 | – | – |
|
|
17
Agnico Eagle Mines
AEM
$72.4B
| $943K | 0.59% | 15,393 +8,493 | +123% | +$520K |
|
|
18
Advanced Micro Devices
AMD
$264B
| $897K | 0.56% | 8,200 -4,150 | -34% | -$454K |
|
19
ASML
ASML
$292B
| $855K | 0.54% | 1,280 | – | – |
|
20
Oshkosh
OSK
$8.92B
| $850K | 0.53% | 8,450 | – | – |
|
21
Altimmune
ALT
$338M
| $810K | 0.51% | 132,978 | – | – |
|
22
Abeona Therapeutics
ABEO
$350M
| $709K | 0.45% | 2,215,740 | – | – |
|
23
OR Royalties Inc.
OR
$6.05B
| $612K | 0.38% | 190,000 | – | – |
|
|
24
Spero Therapeutics
SPRO
$116M
| $609K | 0.38% | +70,000 | New | +$609K |
|
25
Franco-Nevada
FNV
$36.3B
| $598K | 0.38% | 3,750 | – | – |
|